학술논문

Survival of crizotinib continuation plus brain radiotherapy among ALK positive non-small cell lung cancer (NSCLC) patients with brain metastases during crizotinib treatment.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAY 20 2018, 36 15, 1p. Supplement: S
Subject
Language
English
ISSN
15277755